Journal Mobile Options
Table of Contents
Vol. 73, No. 4, 2004
Issue release date: July–August 2004
Psychother Psychosom 2004;73:255–258
(DOI:10.1159/000077745)

Reintroduction of Antidepressant Therapy across Pregnancy in Women Who Previously Discontinued Treatment

A Preliminary Retrospective Study

Cohen L.S. · Altshuler L.L. · Stowe Z.N. · Faraone S.V.
aPerinatal and Reproductive Psychiatry Clinical Research Program, bDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., cMood Disorders Research Program, Department of Psychiatry and Behavioral Medicine, University of California, Los Angeles, Calif., and dPregnancy and Postpartum Mood Disorders Program, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Ga., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Pregnancy has frequently been described as a time of emotional well-being conferring ‘protection’ against psychiatric disorders. However, data to support this impression are sparse. Methods: A retrospective review was undertaken in order to examine rates of reintroduction of antidepressants across pregnancy among a cohort of 54 euthymic pregnant women who had discontinued these medications around the time of conception. Reintroduction of antidepressants was used as a marker suggesting relapse of depression. Results: Forty-two percent (n = 23) of these women reintroduced antidepressant therapy during pregnancy, with nearly half of these (n = 11) doing so in the first trimester. A greater time spent in episodes since depressive onset and a prior history of suicide attempts was associated with antidepressant reintroduction. Conclusions: Nearly half of the women who discontinued antidepressants during pregnancy to avoid fetal exposure appeared to experience symptoms severe enough to prompt reintroduction of treatment with these medications. The implications of these findings are discussed with respect to treatment planning for women who are maintained on antidepressants and who plan to conceive.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Zajicek E: Psychiatric problems during pregnancy; in Wolkind S, Zajicek E (eds): Pregnancy: A Psychological and Social Study. London, Academic, 1981, pp 57–73.
  2. Kendell RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150:662–673.
  3. O’Hara MW, Zekoski EM, Phillips LH, Wright EJ: A controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women. J Abnorm Psychol 1990;99:3–15.
  4. Evans J, Heron J, Francomb H, Oke S, Golding J: Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001;323:257–260.
  5. Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP: The expert consensus guidelines. Treatment of depression in women (review). Postgrad Med 2001, pp 1–107.
  6. Mueller T, Leon A, Keller MB, Solomon DA, Endicott J, Coryell W, Warshaw M, Maser JD: Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000–1006.
  7. Keller MB, Lavori PW, Lewis C, Klerman GL: Predictors of relapse in major depressive disorder. JAMA 1983;250:3299–3309.
  8. Kulin N, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, Ormond K, Matsui D, Stein-Schechman AK, Cook L, Brochu J, Rieder M, Koren G: Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study. JAMA 1998;279:609–610.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00